Annual CAPEX
N/A
December 31, 2023
Summary
- AVTX annual capital expenditures is not available.
Performance
AVTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- AVTX quarterly capital expenditures is not available.
Performance
AVTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- AVTX TTM capital expenditures is not available.
Performance
AVTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
AVTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Avalo Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $95.00 K(-15.9%) | $0.00(-100.0%) | $95.00 K(-10.4%) |
| Sep 2022 | - | $39.00 K(-30.4%) | $106.00 K(-28.4%) |
| Jun 2022 | - | $56.00 K(+409.1%) | $148.00 K(+31.0%) |
| Dec 2021 | $113.00 K(+79.4%) | $11.00 K(-86.4%) | $113.00 K(+10.8%) |
| Sep 2021 | - | $81.00 K(>+9900.0%) | $102.00 K(+21.4%) |
| Jun 2021 | - | $0.00(-100.0%) | $84.00 K(0.0%) |
| Mar 2021 | - | $21.00 K(>+9900.0%) | $84.00 K(+33.3%) |
| Dec 2020 | $63.00 K(-76.0%) | $0.00(-100.0%) | $63.00 K(0.0%) |
| Sep 2020 | - | $63.00 K(>+9900.0%) | $63.00 K(-76.0%) |
| Dec 2019 | $262.00 K | $0.00(-100.0%) | $262.10 K(-65.6%) |
| Sep 2019 | - | $5100.00(-94.4%) | $761.50 K(-4.3%) |
| Jun 2019 | - | $91.00 K(-45.2%) | $795.50 K(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $166.00 K(-66.8%) | $711.20 K(+26.0%) |
| Dec 2018 | $564.40 K(+2322.3%) | $499.40 K(+1177.2%) | $564.40 K(+602.9%) |
| Sep 2018 | - | $39.10 K(+483.6%) | $80.30 K(+69.4%) |
| Jun 2018 | - | $6700.00(-65.1%) | $47.40 K(+16.5%) |
| Mar 2018 | - | $19.20 K(+25.5%) | $40.70 K(+74.7%) |
| Dec 2017 | $23.30 K(-33.2%) | $15.30 K(+146.8%) | $23.30 K(+35.5%) |
| Sep 2017 | - | $6200.00(>+9900.0%) | $17.20 K(-1.7%) |
| Jun 2017 | - | $0.00(-100.0%) | $17.50 K(-37.1%) |
| Mar 2017 | - | $1800.00(-80.4%) | $27.80 K(+6.9%) |
| Dec 2016 | $34.90 K | $9200.00(+41.5%) | $26.00 K(+54.8%) |
| Sep 2016 | - | $6500.00(-36.9%) | $16.80 K(+63.1%) |
| Jun 2016 | - | $10.30 K | $10.30 K |
FAQ
- What is the all time high annual CAPEX for Avalo Therapeutics?
- What is the all time high quarterly CAPEX for Avalo Therapeutics?
- What is the all time high TTM CAPEX for Avalo Therapeutics?
What is the all time high annual CAPEX for Avalo Therapeutics?
Avalo Therapeutics all-time high annual capital expenditures is $564.40 K
What is the all time high quarterly CAPEX for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly capital expenditures is $499.40 K
What is the all time high TTM CAPEX for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM capital expenditures is $795.50 K